APP c.215A>G ;(p.Y72C)

Variant ID: 21-27484306-T-C

NM_000484.3(APP):c.215A>G;(p.Y72C)

This variant was identified in 2 publications

View GRCh38 version.




Publications:


Natural and cryptic peptides dominate the immunopeptidome of atypical teratoid rhabdoid tumors.

Journal For Immunotherapy Of Cancer
Marcu, Ana A; Schlosser, Andreas A; Keupp, Anne A; Trautwein, Nico N; Johann, Pascal P; Wölfl, Matthias M; Lager, Johanna J; Monoranu, Camelia Maria CM; Walz, Juliane S JS; Henkel, Lisa M LM; Krauß, Jürgen J; Ebinger, Martin M; Schuhmann, Martin M; Thomale, Ulrich Wilhelm UW; Pietsch, Torsten T; Klinker, Erdwine E; Schlegel, Paul G PG; Oyen, Florian F; Reisner, Yair Y; Rammensee, Hans-Georg HG; Eyrich, Matthias M
Publication Date: 2021-10

Variant appearance in text: APP: Y72C
PubMed Link: 34599019
Variant Present in the following documents:
  • jitc-2021-003404supp008.pdf
View BVdb publication page



Aromatase inhibition remodels the clonal architecture of estrogen-receptor-positive breast cancers.

Nature Communications
Miller, Christopher A CA; Gindin, Yevgeniy Y; Lu, Charles C; Griffith, Obi L OL; Griffith, Malachi M; Shen, Dong D; Hoog, Jeremy J; Li, Tiandao T; Larson, David E DE; Watson, Mark M; Davies, Sherri R SR; Hunt, Kelly K; Suman, Vera J VJ; Snider, Jacqueline J; Walsh, Thomas T; Colditz, Graham A GA; DeSchryver, Katherine K; Wilson, Richard K RK; Mardis, Elaine R ER; Ellis, Matthew J MJ
Publication Date: 2016-08-09

Variant appearance in text: APP: Y72C
PubMed Link: 27502118
Variant Present in the following documents:
  • ncomms12498-s3.xls, sheet 1
View BVdb publication page